Achieve Life Sciences, Inc. SEC filings ACHV

Achieve Life Sciences, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Apr 15, 2009. Its latest annual report, Form ARS, was filed on Jun 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Jun 8, 2026 Dec 31, 2025
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
10-K Annual report Mar 24, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
10-K Annual report Mar 11, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
10-K Annual report Mar 28, 2024 Dec 31, 2023
10-K/A Amended annual report May 16, 2023 Dec 31, 2022
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
10-K Annual report Mar 16, 2023 Dec 31, 2022
10-K Annual report Mar 10, 2022 Dec 31, 2021
10-K Annual report Mar 11, 2021 Dec 31, 2020
10-K Annual report Mar 13, 2020 Dec 31, 2019
10-K Annual report Mar 14, 2019 Dec 31, 2018
10-K Annual report Mar 1, 2018 Dec 31, 2017
10-K Annual report Feb 23, 2017 Dec 31, 2016
10-K Annual report Mar 9, 2016 Dec 31, 2015
10-K Annual report Mar 26, 2015 Dec 31, 2014
ARS Annual report to shareholders Apr 30, 2014 Dec 31, 2013
10-K Annual report Mar 11, 2014 Dec 31, 2013
ARS Annual report to shareholders May 3, 2013 Dec 31, 2012
10-K Annual report Mar 7, 2013 Dec 31, 2012
ARS Annual report to shareholders Jun 4, 2012 Dec 31, 2011
10-K Annual report Mar 8, 2012 Dec 31, 2011
ARS Annual report to shareholders Apr 29, 2011 Dec 31, 2010
10-K Annual report Mar 10, 2011 Dec 31, 2010
10-K Annual report Mar 8, 2010 Dec 31, 2009

Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
ACHV (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Seattle, WA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
949858
Former names
ONCOGENEX PHARMACEUTICALS, INC. (until Jul 31, 2017); SONUS PHARMACEUTICALS INC (until Aug 7, 2008)

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.